Why insider trading matters?
What separates FormWhispers.com from others is that we created it to meet our own needs and we use it everyday to make better investment decisions. We will keep improving it to serve us better and to serve you better.
Gritstone Oncology, Inc., an immuno-oncology company, engages in developing tumor-specific cancer immunotherapies to fight various cancer types.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2021-05-27 | Rousseau Raphael | nan | Sell | 2,900 | $9.00 | $26,112 | Yes |
| 2021-01-20 | Rousseau Raphael | nan | Sell | 30,000 | $20.04 | $601,269 | Yes |
| 2021-01-19 | Yelensky Roman | nan | Sell | 10,000 | $22.10 | $221,029 | No |
| 2020-12-30 | Woiwode Thomas | Director | Buy | 1,347,709 | $3.71 | $5,000,000 | No |
| 2019-08-21 | Rousseau Raphael | See Remarks | Sell | 10,000 | $10.76 | $107,631 | Yes |
| 2018-09-28 | Simon Nicholas | 10%-Owner, Director | Buy | 333,333 | $15.00 | $4,999,995 | Yes |
| 2018-09-28 | Clarus Lifesciences III, L.P. | 10%-Owner | Buy | 333,333 | $15.00 | $4,999,995 | Yes |
Insider Smart
Insider Smart